Gabbay E, Avraham Y, Berry EM, Ilan Y, Zolotrev O, Okun A, Yisraeli E (2003) Treatment with an endocannabinoid antagonist improves neurological function and survival in an animal model of fulminant hepatic failure. Hepatology 38: 541a-541a
Gadzicki D, Muller-Vahl K, Stuhrmann M (1999) A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene. Mol Cell Probes 13: 321-323
Gadzicki D, Muller-Vahl KR, Heller D, Ossege S, Nothen MM, Hebebrand J, Stuhrmann M (2004) Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene. Am J Med Genet 127B: 97-103
Gaetani S, Cuomo V, Piomelli D (2003) Anandamide hydrolysis: a new target for anti-anxiety drugs? Trends Mol Med 9: 474-478
Gaetani S, Oveisi F, Piomelli D (2003) Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacology 28: 1311-1316
Gahwiler B (1981) Organotypic monolayer cultures of nervous tissue. J Neurosci 4: 329-342
Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232: 54-61
Gallate JE, McGregor IS (1999) The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology (Berl) 142: 302-308
Gallate JE, Saharov T, Mallet PE, McGregor IS (1999) Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 370: 233-240
Galli C, Marangoni F (1997) Recent advances in the biology of n-6 fatty acids. Nutrition 13: 978-985
Gallily R, Breuer A, Mechoulam R (2000) 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice. Eur J Pharmacol 406: R5-7
Galve-Roperh I, Rueda D, Martinez-Serrano A, Guzman M (2003) Cannabinoid inhibition of neuronal differentiation. Journal of Neurochemistry 87
Gammon CM, Freeman GM, Xie W, Wetsel WC (2003) Endocannabinoid signaling in immortalized hypothalamic lhrh neurons. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Garabette ML, Martin KF, Redfern PH (2000) Circadian variation in the activity of the 5-HT(1B) autoreceptor in the region of the suprachiasmatic nucleus, measured by microdialysis in the conscious freely-moving rat. Br J Pharmacol 131: 1569-1576
Garcia DE, Brown S, Hille B, Mackie K (1998) Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J Neurosci 18: 2834-2841
Garcia N, Jr., Jarai Z, Mirshahi F, Kunos G, Sanyal AJ (2001) Systemic and portal hemodynamic effects of anandamide. Am J Physiol Gastrointest Liver Physiol 280: G14-20
Gardener MJ, Johnson IT, Burnham MP, Edwards G, Heagerty AM, Weston AH (2004) Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol 142: 192-202
Gardiner SM, March JE, Kemp PA, Bennett T (2002) beta2-Adrenoceptor involvement in the hindquarters vasodilator effects of WIN 55212-2, HU 210 and anandamide in conscious Sprague-Dawley rats. British Journal of Pharmacology 135
Gardiner SM, March JE, Kemp PA, Bennett T (2002) Complex regional haemodynamic effects of anandamide in conscious rats. Br J Pharmacol 135: 1889-1896
Gardner B, Zhu LX, Sharma S, Tashkin DP, Dubinett SM (2003) Methanandamide increases COX-2 expression and tumor growth in murine lung cancer. Faseb J 17: 2157-2159
Gardner B, Zu LX, Sharma S, Liu Q, Makriyannis A, Tashkin DP, Dubinett SM (2002) Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-beta. Biochem Biophys Res Commun 290: 91-96
Gaskari SA, Li Y, Liu H, Lee SS (2003) Role of endocannabinoid system in the genesis of cirrhotic cardiomyopathy. Hepatology 38: 198a-198a
Gatley SJ, Gifford AN, Volkow ND, Lan R, Makriyannis A (1996) 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur J Pharmacol 307: 331-338
Gatley SJ, Lan R, Pyatt B, Gifford AN, Volkow ND, Makriyannis A (1997) Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci 61: PL 191-197
Gatley SJ, Lan R, Volkow ND, Pappas N, King P, Wong CT, Gifford AN, Pyatt B, Dewey SL, Makriyannis A (1998) Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo. J Neurochem 70: 417-423
Gauldie SD, McQueen DS, Pertwee R, Chessell IP (2001) Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints. Br J Pharmacol 132: 617-621
Gaus K, Basran A, Hall EA (2001) Assessment of the fifth ligand-binding repeat (LR5) of the LDL receptor as an analytical reagent for LDL binding. Analyst 126: 329-336
Gaus K, Hall EA (2003) Short peptide receptor mimics for atherosclerosis risk assessment of LDL. Biosens Bioelectron 18: 151-164
Gavva NR, Klionsky L, Qu Y, Shi L, Tamir R, Edenson S, Zhang TJ, Viswanadhan VN, Toth A, Pearce LV, Vanderah TW, Porreca F, Blumberg PM, Lile J, Sun Y, Wild K, Louis JC, Treanor JJ (2004) Molecular Determinants of Vanilloid Sensitivity in TRPV1. J Biol Chem 279: 20283-20295
Gebremedhin D, Lange AR, Campbell WB, Hillard CJ, Harder DR (1999) Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. Am J Physiol 276: H2085-2093
Genazzani AA, Billington RA (2002) NAADP: an atypical Ca2+-release messenger? Trends Pharmacol Sci 23: 165-167
George S, Johansen A, Soos MA, Mortensen H, Gammeltoft S, Saudek V, Siddle K, Hansen L, O'Rahilly S (2003) Deletion of V335 from the L2 domain of the insulin receptor results in a conformationally abnormal receptor that is unable to bind insulin and causes Donohue's syndrome in a human subject. Endocrinology 144: 631-637
Geraghty DP, Mazzone SB (2002) Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferatoxin with non-pungent agents and anandamide. Br J Pharmacol 137: 919-927
Gerdeman G, Lovinger DM (2001) CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol 85: 468-471
Gerdeman GL, Lovinger DM (2001) CB1 cannabinoid receptors are critical for induction of striatal long term depression. Society for Neuroscience Abstracts 27
Gerdeman GL, Lovinger DM (2003) Emerging roles for endocannabinoids in long-term synaptic plasticity. British Journal of Pharmacology 140: 781-789
Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM (2003) It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 26: 184-192
Gerdeman GL, Ronesi J, Lovinger DM (2002) Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 5: 446-451
Gerdeman GL, Ronesi J, Lovinger DM (2002) Striatal Long Term Depression Depends on Efflux of Retrograde Endocannabinoids Via Reverse Transport. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002
Germain N, Boichot E, Advenier C, Berdyshev EV, Lagente V (2002) Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-alpha production by human mononuclear cells. Int Immunopharmacol 2: 537-543
Germano MP, D'Angelo V, Mondello MR, Pergolizzi S, Capasso F, Capasso R, Izzo AA, Mascolo N, De Pasquale R (2001) Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats. Naunyn Schmiedebergs Arch Pharmacol 363: 241-244
Gerwick WH, Wise ML, Soderstrom K, Murray TF (1997) Biosynthesis and cannabinoid receptor affinity of the novel eicosanoid, conjugated triene anandamide. Adv Exp Med Biol 407: 329-334
Gessa GL, Casu MA, Carta G, Mascia MS (1998) Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A. Eur J Pharmacol 355: 119-124
Gessa GL, Melis M, Muntoni AL, Diana M (1998) Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 341: 39-44
Gherardi E, Youles ME, Miguel RN, Blundell TL, Iamele L, Gough J, Bandyopadhyay A, Hartmann G, Butler PJ (2003) Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A 100: 12039-12044
Giang DK, Cravatt BF (1997) Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci U S A 94: 2238-2242
Giannini G, Conti A, Mammarella S, Scrobogna M, Sorrentino V (1995) The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J Cell Biol 128: 893-904
Gifford AN, Bruneus M, Gatley SJ, Lan R, Makriyannis A, Volkow ND (1999) Large receptor reserve for cannabinoid actions in the central nervous system. J Pharmacol Exp Ther 288: 478-483
Gifford AN, Bruneus M, Lin S, Goutopoulos A, Makriyannis A, Volkow ND, Gatley SJ (1999) Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374). Eur J Pharmacol 383: 9-14
Gifford AN, Makriyannis A, Volkow ND, Gatley SJ (2002) In vivo imaging of the brain cannabinoid receptor. Chem Phys Lipids 121: 65-72
Gilbard JP, Dartt DA (1982) Changes in rabbit lacrimal gland fluid osmolarity with flow rate. Invest Ophthalmol Vis Sci 23: 804-806
Gilgun-Sherki Y, Melamed E, Mechoulam R, Offen D (2003) The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned rats. Pharmacol Toxicol 93: 66-70
Gillingham AK, Pfeifer AC, Munro S (2002) CASP, the alternatively spliced product of the gene encoding the CCAAT-displacement protein transcription factor, is a Golgi membrane protein related to giantin. Mol Biol Cell 13: 3761-3774
Gilon P, Bird GJ, Bian X, Yakel JL, Putney JW, Jr. (1995) The Ca(2+)-mobilizing actions of a Jurkat cell extract on mammalian cells and Xenopus laevis oocytes. J Biol Chem 270: 8050-8055
Ginsborg BL, House CR (1980) Stimulus-response coupling in gland cells. Annu Rev Biophys Bioeng 9: 55-80
Giuffrida A, Beltramo M, Piomelli D (2001) Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J Pharmacol Exp Ther 298: 7-14
Giuffrida A, Desarnaud F, Piomelli D (2000) Endogenous cannabinoid signaling and psychomotor disorders. Prostaglandins Other Lipid Mediat 61: 63-70
Giuffrida A, Ferrer B, Asbrock N, Le S, Piomelli D (2002) Endocannabinoid Dysregulation in 6 - Ohda - Lesioned Rats. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002
Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2: 358-363
Giuffrida A, Piomelli D (1998) Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett 422: 373-376
Giuffrida A, Piomelli D (1999) Purification and high-resolution analysis of anandamide and other fatty acylethanolamides. In SG Laycock, RP Rubin, eds, Lipid Second Messengers. CRC Press, Boca Raton, pp 113-133
Giuffrida A, Piomelli D (2000) The endocannabinoid system: a physiological perspective on its role in psychomotor control. Chem Phys Lipids 108: 151-158
Giuffrida A, Piomelli D, Solbrig M (2003) Extrapyramidal endocannabinoid dysregulation in viral - induced dyskinesias. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Giuffrida A, Rodriguez de Fonseca F, Nava F, Loubet-Lescoulie P, Piomelli D (2000) Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. Eur J Pharmacol 408: 161-168
Giuffrida A, Rodriguez de Fonseca F, Piomelli D (2000) Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal Biochem 280: 87-93
Giussani DA, Gardner DS, Cox DT, Fletcher AJ (2001) Purinergic contribution to circulatory, metabolic, and adrenergic responses to acute hypoxemia in fetal sheep. Am J Physiol Regul Integr Comp Physiol 280: R678-685
Giussani DA, Riquelme RA, Sanhueza EM, Hanson MA, Blanco CE, Llanos AJ (1999) Adrenergic and vasopressinergic contributions to the cardiovascular response to acute hypoxaemia in the llama fetus. J Physiol 515 (Pt 1): 233-241
Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch DG (2003) Evidence against the presence of an anandamide transporter. Proc Natl Acad Sci U S A 100: 4269-4274
Glass M (2001) The role of cannabinoids in neurodegenerative diseases. Prog Neuropsychopharmacol Biol Psychiatry 25: 743-765
Glass M, Felder CC (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 17: 5327-5333
Glass M, Northup JK (1999) Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors. Mol Pharmacol 56: 1362-1369
Glass M, van Dellen A, Blakemore C, Hannan AJ, Faull RL (2004) Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors. Neuroscience 123: 207-212
Glebov OO, Nichols BJ (2004) Lipid raft proteins have a random distribution during localized activation of the T-cell receptor. Nat Cell Biol 6: 238-243
Glen AI, Cooper SJ, Rybakowski J, Vaddadi K, Brayshaw N, Horrobin DF (1996) Membrane fatty acids, niacin flushing and clinical parameters. Prostaglandins Leukot Essent Fatty Acids 55: 9-15
Glencorse TA, Bateson AN, Darlison MG (1992) Differential Localization of Two Alternatively Spliced GABAA Receptor gamma2-Subunit mRNAs in the Chick Brain. Eur J Neurosci 4: 271-277
Godfrey PP, Putney JW, Jr. (1984) Receptor-mediated metabolism of the phosphoinositides and phosphatidic acid in rat lacrimal acinar cells. Biochem J 218: 187-195
Goldberg M, Lecolle S, Lesot H, Ruch JV (1990) Effects of cerulenin, an inhibitor of fatty acid synthesis on reconstitution of the dental basement membrane. Biol Cell 69: 27-33
Gomez del Pulgar T, Velasco G, Guzman M (2000) The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem J 347: 369-373
Gomez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodriguez de Fonseca F (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22: 9612-9617
Gomez TM, Spitzer NC (1999) In vivo regulation of axon extension and pathfinding by growth-cone calcium transients. Nature 397: 350-355
Gomperts SN (1996) Clustering membrane proteins: It's all coming together with the PSD-95/SAP90 protein family. Cell 84: 659-662
Gongora C, Hose S, O'Brien TP, Sinha D (2004) Downregulation of class II transactivator (CIITA) expression by synthetic cannabinoid CP55,940. Immunol Lett 91: 11-16
Gonsiorek W, Lunn C, Fan X, Narula S, Lundell D, Hipkin RW (2000) Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol Pharmacol 57: 1045-1050
Gonzalez-Maeso J, Wise A, Green A, Koenig JA (2003) Agonist-induced desensitization and endocytosis of heterodimeric GABAB receptors in CHO-K1 cells. Eur J Pharmacol 481: 15-23
Gonzalez-Perrett S, Kim K, Ibarra C, Damiano AE, Zotta E, Batelli M, Harris PC, Reisin IL, Arnaout MA, Cantiello HF (2001) Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci U S A 98: 1182-1187
Gonzalez-Reyes A, St Johnston D (1998) Patterning of the follicle cell epithelium along the anterior-posterior axis during Drosophila oogenesis. Development 125: 2837-2846
Gonzalez S, Bisogno T, Wenger T, Manzanares J, Milone A, Berrendero F, Di Marzo V, Ramos JA, Fernandez-Ruiz JJ (2000) Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. Biochem Biophys Res Commun 270: 260-266
Gonzalez S, Cascio MG, Fernandez-Ruiz J, Fezza F, Di Marzo V, Ramos JA (2002) Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 954: 73-81
Gonzalez S, Fernandez-Ruiz J, Marzo VD, Hernandez M, Arevalo C, Nicanor C, Cascio MG, Ambrosio E, Ramos JA (2004) Behavioral and molecular changes elicited by acute administration of SR141716 to Delta(9)-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. Drug Alcohol Depend 74: 159-170
Gonzalez S, Fernandez-Ruiz J, Sparpaglione V, Parolaro D, Ramos JA (2002) Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels. Drug Alcohol Depend 66: 77-84
Gonzalez S, Manzanares J, Berrendero F, Wenger T, Corchero J, Bisogno T, Romero J, Fuentes JA, Di Marzo V, Ramos JA, Fernandez-Ruiz J (1999) Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland. Neuroendocrinology 70: 137-145
Gonzalez S, Mauriello-Romanazzi G, Berrendero F, Ramos JA, Franzoni MF, Fernandez-Ruiz J (2000) Decreased cannabinoid CB1 receptor mRNA levels and immunoreactivity in pituitary hyperplasia induced by prolonged exposure to estrogens. Pituitary 3: 221-226
Gonzalez S, Romero J, de Miguel R, Lastres-Becker I, Villanua MA, Makriyannis A, Ramos JA, Fernandez-Ruiz JJ (1999) Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide. Life Sci 65: 327-336
Gonzalez S, Schmid PC, Fernandez-Ruiz J, Krebsbach R, Schmid HH, Ramos JA (2003) Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats. Addict Biol 8: 159-166
Goode EL, Dunning AM, Kuschel B, Healey CS, Day NE, Ponder BA, Easton DF, Pharoah PP (2002) Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res 62: 3052-3057
Goodfellow PN, Camerino G (2001) DAX-1, an "antitestis" gene. Exs: 57-69
Gopal KV, Gross GW (2004) Unique responses of auditory cortex network in vitro to low concentrations of quinine. Hearing Research In Press
Goparaju SK, Kurahashi Y, Suzuki H, Ueda N, Yamamoto S (1999) Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis(1). Biochim Biophys Acta 1441: 77-84
Goparaju SK, Ueda N, Taniguchi K, Yamamoto S (1999) Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem Pharmacol 57: 417-423
Goparaju SK, Ueda N, Yamaguchi H, Yamamoto S (1998) Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett 422: 69-73
Gorriti MA, Rodriguez de Fonseca F, Navarro M, Palomo T (1999) Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats. Eur J Pharmacol 365: 133-142
Gothert M, Bruss M, Bonisch H, Molderings GJ (1999) Presynaptic imidazoline receptors. New developments in characterization and classification. Ann N Y Acad Sci 881: 171-184
Goutopoulos A, Fan P, Khanolkar AD, Xie XQ, Lin S, Makriyannis A (2001) Stereochemical selectivity of methanandamides for the CB1 and CB2 cannabinoid receptors and their metabolic stability. Bioorg Med Chem 9: 1673-1684
Goutopoulos A, Makriyannis A (2002) From cannabis to cannabinergics: new therapeutic opportunities. Pharmacol Ther 95: 103-117
Gower NJ, Temple GR, Schein JE, Marra M, Walker DS, Baylis HA (2001) Dissection of the promoter region of the inositol 1,4,5-trisphosphate receptor gene, itr-1, in C. elegans: a molecular basis for cell-specific expression of IP3R isoforms. J Mol Biol 306: 145-157
Goya P, Jagerovic N, Hernandez-Folgado L, Martin MI (2003) Cannabinoids and neuropathic pain. Mini Rev Med Chem 3: 765-772
Grahames CB, Michel AD, Chessell IP, Humphrey PP (1999) Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes. Br J Pharmacol 127: 1915-1921
Grainger DJ, Frow EK (2000) Thrombospondin 1 does not activate transforming growth factor beta1 in a chemically defined system or in smooth-muscle-cell cultures. Biochem J 350 Pt 1: 291-298
Grainger J, Boachie-Ansah G (2001) Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br J Pharmacol 134: 1003-1012
Grammatikopoulos G, Pignatelli M, Giuliano A, Ruocco L, Scamardella M, Sadile AG (2001) Blockade of the CB1 endocannabinoid receptor modulates activity and non-selective attention in the Naples High Excitability rat. Society for Neuroscience Abstracts 27
Granberg M, Fowler CJ, Jacobsson SO (2001) Effects of the cannabimimetic fatty acid derivatives 2-arachidonoylglycerol, anandamide, palmitoylethanolamide and methanandamide upon IgE-dependent antigen-induced beta-hexosaminidase, serotonin and TNF alpha release from rat RBL-2H3 basophilic leukaemic cells. Naunyn Schmiedebergs Arch Pharmacol 364: 66-73
Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ, Robbins TW (2000) Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20: 1208-1215
Gray J, Jerman JC, Ooi LC, Brough SJ, Owen DE, Smart D, Davis JB (2001) Primary and recombinant rat VR1 responses to cannabinoids. Society for Neuroscience Abstracts 27
Grayson C, Reid SN, Ellis JA, Rutherford A, Sowden JC, Yates JR, Farber DB, Trump D (2000) Retinoschisin, the X-linked retinoschisis protein, is a secreted photoreceptor protein, and is expressed and released by Weri-Rb1 cells. Hum Mol Genet 9: 1873-1879
Grazia Cascio M, Minassi A, Ligresti A, Appendino G, Burstein S, Di Marzo V (2004) A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 314: 192-196
Green PS, Simpkins JW (2000) Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease. Ann N Y Acad Sci 924: 93-98
Green PS, Simpkins JW (2000) Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18: 347-358
Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73: 2424-2428
Greferath U, Grunert U, Fritschy JM, Stephenson A, Mohler H, Wassle H (1995) GABAA receptor subunits have differential distributions in the rat retina: in situ hybridization and immunohistochemistry. J Comp Neurol 353: 553-571
Greferath U, Grunert U, Muller F, Wassle H (1994) Localization of GABAA receptors in the rabbit retina. Cell Tissue Res 276: 295-307
Gribble FM, Reimann F (2002) Pharmacological modulation of K(ATP) channels. Biochem Soc Trans 30: 333-339
Gribble FM, Reimann F (2003) Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions. J Diabetes Complications 17: 11-15
Gribble FM, Reimann F (2003) Sulphonylurea action revisited: the post-cloning era. Diabetologia 46: 875-891
Griffin G, Atkinson PJ, Showalter VM, Martin BR, Abood ME (1998) Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes. J Pharmacol Exp Ther 285: 553-560
Griffin G, Fernando SR, Ross RA, McKay NG, Ashford ML, Shire D, Huffman JW, Yu S, Lainton JA, Pertwee RG (1997) Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Eur J Pharmacol 339: 53-61
Griffin G, Tao Q, Abood ME (2000) Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor. J Pharmacol Exp Ther 292: 886-894
Griffin G, Wray EJ, Rorrer WK, Crocker PJ, Ryan WJ, Saha B, Razdan RK, Martin BR, Abood ME (1999) An investigation into the structural determinants of cannabinoid receptor ligand efficacy. Br J Pharmacol 126: 1575-1584
Griffin G, Wray EJ, Tao Q, McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME (1999) Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system. Eur J Pharmacol 377: 117-125
Grisshammer R, Hermans E (2001) Functional coupling with Galpha(q) and Galpha(i1) protein subunits promotes high-affinity agonist binding to the neurotensin receptor NTS-1 expressed in Escherichia coli. FEBS Lett 493: 101-105
Gromada J, Jorgensen TD, Dissing S (1995) Cyclic ADP-ribose and inositol 1,4,5-triphosphate mobilizes Ca2+ from distinct intracellular pools in permeabilized lacrimal acinar cells. FEBS Lett 360: 303-306
Gromada J, Jorgensen TD, Dissing S (1995) The release of intracellular Ca2+ in lacrimal acinar cells by alpha-, beta-adrenergic and muscarinic cholinergic stimulation: the roles of inositol triphosphate and cyclic ADP-ribose. Pflugers Arch 429: 751-761
Gromada J, Jorgensen TD, Dissing S (1995) Role of protein kinase C in the regulation of inositol phosphate production and Ca2+ mobilization evoked by ATP and acetylcholine in rat lacrimal acini. Pflugers Arch 429: 578-586
Gromada J, Jorgensen TD, Tritsaris K, Nauntofte B, Dissing S (1993) Ca2+ signalling in exocrine acinar cells: the diffusional properties of cellular inositol 1,4,5-trisphosphate and its role in the release of Ca2+. Cell Calcium 14: 711-723
Gross A, Bouaboula M, Casellas P, Liautard JP, Dornand J (2003) Subversion and utilization of the host cell cyclic adenosine 5'-monophosphate/protein kinase A pathway by Brucella during macrophage infection. J Immunol 170: 5607-5614
Gross A, Terraza A, Marchant J, Bouaboula M, Ouahrani-Bettache S, Liautard JP, Casellas P, Dornand J (2000) A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suis. J Leukoc Biol 67: 335-344
Gross GW (1979) Simultaneous single unit recording in vitro with a photoetched laser deinsulated gold multimicroelectrode surface. IEEE Trans Biomed Eng 26: 273-279
Gross GW (1994) Internal dynamics of randomized mammalian neuronal networks in culture. In DA Stenger, TM McKenna, eds, Enabling technologies for cultured neural networks. Academic Press, New York, pp 277-317
Gross GW, Harsch A, Rhoades BK, Gopel W (1997) Odor, drug and toxin analysis with neuronal networks in vitro: extracellular array recording of network responses. Biosens Bioelectron 12: 373-393
Gross GW, Kowalski JM (1991) Experimental and theoretical analyses of random network dynamics. In A Milutinovic, ed, Neural networks, concepts, application and implementation, Vol 4. Prentice Hall, NJ
Gross GW, Lucas JH (1982) Long-term monitoring of spontaneous single unit activity from neuronal monolayer networks cultured on photoetched multielectrode surfaces. J Electrophys Tech 9: 55-69
Gross GW, Norton S, Gopal K, Schiffmann D, Gramowski A (1997) Nerve cell networks in vitro: applications to neurotoxicology, drug development and biosensors. The Neuroelectronic interface. Cellular Engineering 2: 138-147
Gross GW, Rhoades BK, Jordan RJ (1992) Neuronal networks for biochemical sensing. Sensors and actuators 6: 1-8
Gross GW, Schwalm FU (1994) A closed flow chamber for long-term multichannel recording and optical monitoring. J Neurosci Methods 52: 73-85
Gross GW, Wen WY, Lin JW (1985) Transparent indium-tin oxide electrode patterns for extracellular, multisite recording in neuronal cultures. J Neurosci Methods 15: 243-252
Gubellini P, Picconi B, Bari M, Battista N, Calabresi P, Centonze D, Bernardi G, Finazzi-Agro A, Maccarrone M (2002) Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci 22: 6900-6907
Gueudet C, Santucci V, Rinaldi-Carmona M, Soubrie P, Le Fur G (1995) The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat. Neuroreport 6: 1421-1425
Guhring H, Hamza M, Ates M, Seidel K, Sergejeva M, Kotalla CE, Ledent C, Michaelis M, Brune K (2002) Role of Endocannabinoids in Indomethacin and Flurbiprofen Induced Spinal Antinociception. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002
Guhring H, Hamza M, Sergejeva M, Ates M, Kotalla CE, Ledent C, Brune K (2002) A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol 454: 153-163
Guhring H, Schuster J, Hamza M, Ates M, Kotalla CE, Brune K (2001) HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test. Eur J Pharmacol 429: 127-134
Gula NM (1995) [Department of lipid biochemistry]. Ukr Biokhim Zh 67: 125-128
Gulaia NM, Smirnov IM, Shmal'ko Iu P, Mel'nik AA, Mel'nik SN (1993) [Effect of N-palmitoyl- and N-stearoylethanolamines on lipid peroxidation in mouse tissues in metastatic Lewis carcinoma]. Ukr Biokhim Zh 65: 96-101
Gulaia NM, Vas'kovskii VE, Vysotskii MV, Volkov GL, Govseeva NN (1988) [Detection of N-acylethanolamine phospholipids in neuroblastoma C1300 cells]. Ukr Biokhim Zh 60: 58-63
Gulaya NM, Kuzmendo AI, Margitich VM, Govseeva NM, Melnichuk SD, Goridko TM, Zhukov AD (1998) Long-chain N-acylethanolamines inhibit peroxidation in rat liver mitochondria under acute hypoxic hypoxia. Chemistry and Physics of Lipids 97: 49-54
Gulaya NM, Melnik AA, Balkov DI, Volkov GL, Vysotskiy MV, Vaskovsky VE (1993) The effect of long-chain N-acylethanolamines on some membrane-associated functions of neuroblastoma C1300 N18 cells. Biochim Biophys Acta 1152: 280-288
Gulaya NM, Mikosha AS, Zhukov AD, Chelnakova IS (2000) N-acylethanolamines effects on the adrenal cortex function. Ukrainskii Biokhimicheskii Zhurnal 72: 82-86
Gulaya NM, Volkov GL, Klimashevsky VM, Govseeva NM, Artemenko IP, Gavriliuk ES (1990) Modification of lipid composition of neuroblastoma C1300 N18 cells with liposomes alters the cholesterol content. Neuroscience 34: 785-792
Gulaya NM, Volkov GL, Klimashevsky VM, Govseeva NN, Melnik AA (1989) Changes in lipid composition of neuroblastoma C1300 N18 cell during differentiation. Neuroscience 30: 153-164
Gunhan-Agar E, Kahn D, Chalupa LM (2000) Segregation of on and off bipolar cell axonal arbors in the absence of retinal ganglion cells. J Neurosci 20: 306-314
Gunthorpe MJ, Lummis SC (1999) Diltiazem causes open channel block of recombinant 5-HT3 receptors. J Physiol 519 Pt 3: 713-722
Gunthorpe MJ, Lummis SC (2001) Conversion of the ion selectivity of the 5-HT(3a) receptor from cationic to anionic reveals a conserved feature of the ligand-gated ion channel superfamily. J Biol Chem 276: 10977-10983
Gunthorpe MJ, Rami HK, Jerman JC, Smart D, Gill CH, Soffin EM, Luis Hannan S, Lappin SC, Egerton J, Smith GD, Worby A, Howett L, Owen D, Nasir S, Davies CH, Thompson M, Wyman PA, Randall AD, Davis JB (2004) Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist. Neuropharmacology 46: 133-149
Guo J, Ikeda SR (2003) Endocannabinoids modulate N - type calcium channels and G - protein coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Guo J, Ikeda SR (2004) Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Mol Pharmacol 65: 665-674
Gupta G, Lowe CR (2004) An artificial receptor for glycoproteins. J Mol Recognit 17: 218-235
Gurnell M, Savage DB, Chatterjee VK, O'Rahilly S (2003) The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation. J Clin Endocrinol Metab 88: 2412-2421
Gurnell M, Wentworth JM, Agostini M, Adams M, Collingwood TN, Provenzano C, Browne PO, Rajanayagam O, Burris TP, Schwabe JW, Lazar MA, Chatterjee VK (2000) A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. J Biol Chem 275: 5754-5759
Gurney AM, Osipenko ON, MacMillan D, McFarlane KM, Tate RJ, Kempsill FE (2003) Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. Circ Res 93: 957-964
Gurrola GB, Arevalo C, Sreekumar R, Lokuta AJ, Walker JW, Valdivia HH (1999) Activation of ryanodine receptors by imperatoxin A and a peptide segment of the II-III loop of the dihydropyridine receptor. J Biol Chem 274: 7879-7886
Gurwitz D, Kloog Y (1998) Do endogenous cannabinoids contribute to HIV-mediated immune failure? Mol Med Today 4: 196-200
Gurwitz D, Weizman A (2001) Fatty acid amide hydrolase inhibitors and the marijuana debate. Lancet 358: 1548
Guse AH (2000) Cyclic ADP-ribose. J Mol Med 78: 26-35
Gusntone FD, Harwood JL, Padley FB (1986) The Lipid Handbook. Chapman and Hall, London
Gutierrez S, Diez B, Montenegro E, Martin JF (1991) Characterization of the Cephalosporium acremonium pcbAB gene encoding alpha-aminoadipyl-cysteinyl-valine synthetase, a large multidomain peptide synthetase: linkage to the pcbC gene as a cluster of early cephalosporin biosynthetic genes and evidence of multiple functional domains. J Bacteriol 173: 2354-2365
Guzman M (2003) Cannabinoids: Potential anticancer agents. Nature Reviews Cancer 3: 745-755
Guzman M (2003) Neurons on cannabinoids: dead or alive? British Journal of Pharmacology 140: 439-440
Guzman M, Fernandez-Ruiz JJ, Sanchez C, Velasco G, Ramos JA (1995) Effects of anandamide on hepatic fatty acid metabolism. Biochem Pharmacol 50: 885-888
Guzman M, Lo Verme J, Fu J, Oveisi F, Blazquez C, Piomelli D (2004) Oleoylethanolamide stimulates lipolysis by activating the nucelar receptor PPAR-alpha. J Biol Chem
Guzman M, Sanchez C (1999) Effects of cannabinoids on energy metabolism. Life Sci 65: 657-664
Guzman M, Sanchez C, Galve-Roperh I (2002) Cannabinoids and cell fate. Pharmacol Ther 95: 175-184